These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37325663)

  • 1. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances.
    Marrie RA; Fisk JD; Fitzgerald K; Kowalec K; Maxwell C; Rotstein D; Salter A; Tremlett H
    Front Immunol; 2023; 14():1197195. PubMed ID: 37325663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.
    Marrie RA; Reider N; Cohen J; Stuve O; Trojano M; Cutter G; Reingold S; Sorensen PS
    Mult Scler; 2015 Mar; 21(3):318-31. PubMed ID: 25533300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity in multiple sclerosis: implications for patient care.
    Marrie RA
    Nat Rev Neurol; 2017 Jun; 13(6):375-382. PubMed ID: 28303911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Barancik lecture: Comorbidity in multiple sclerosis-Looking backward, looking forward.
    Marrie RA
    Mult Scler; 2023 Aug; 29(9):1049-1056. PubMed ID: 37125430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.
    Ewanchuk BW; Gharagozloo M; Peelen E; Pilutti LA
    Mult Scler Relat Disord; 2018 Nov; 26():19-32. PubMed ID: 30216755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
    Diržiuvienė B; Mickevičienė D
    Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular comorbidities in the onset and progression of multiple sclerosis.
    Tettey P; Simpson S; Taylor BV; van der Mei IA
    J Neurol Sci; 2014 Dec; 347(1-2):23-33. PubMed ID: 25454639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
    Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
    J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity.
    Neto LO; Ruiz JA; Gromisch ES
    Qual Life Res; 2024 Feb; 33(2):573-581. PubMed ID: 37966685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
    Hauer L; Perneczky J; Sellner J
    J Neurol; 2021 Nov; 268(11):4066-4077. PubMed ID: 32719975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of comorbidity in multiple sclerosis.
    Ponzio M; Monti MC; Mallucci G; Borrelli P; Fusco S; Tacchino A; Brichetto G; Tronconi L; Montomoli C; Bergamaschi R
    Neurol Sci; 2023 Mar; 44(3):999-1008. PubMed ID: 36441342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study.
    Al-Sakran L; Marrie RA; Blackburn D; Knox K; Evans C
    Mult Scler Relat Disord; 2020 May; 40():101955. PubMed ID: 32000120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis.
    Chen J; Taylor B; Winzenberg T; Palmer AJ; Kirk-Brown A; van Dijk P; Simpson S; Blizzard L; van der Mei I
    Mult Scler; 2020 Oct; 26(12):1550-1559. PubMed ID: 33063620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
    Marck CH; Neate SL; Taylor KL; Weiland TJ; Jelinek GA
    PLoS One; 2016; 11(2):e0148573. PubMed ID: 26849357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis.
    Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; van der Mei I
    J Neurol; 2021 Feb; 268(2):602-612. PubMed ID: 32880720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between comorbidity and clinical characteristics of MS.
    Marrie RA; Horwitz RI; Cutter G; Tyry T; Vollmer T
    Acta Neurol Scand; 2011 Aug; 124(2):135-41. PubMed ID: 20880264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study.
    Boesen MS; Blinkenberg M; Thygesen LC; Eriksson F; Magyari M
    Mult Scler; 2021 Feb; 27(2):259-267. PubMed ID: 32975459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Thormann A; Sørensen PS; Koch-Henriksen N; Laursen B; Magyari M
    Neurology; 2017 Oct; 89(16):1668-1675. PubMed ID: 28931645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for observational studies of comorbidity in multiple sclerosis.
    Marrie RA; Miller A; Sormani MP; Thompson A; Waubant E; Trojano M; O'Connor P; Fiest K; Reider N; Reingold S; Cohen JA;
    Neurology; 2016 Apr; 86(15):1446-1453. PubMed ID: 26865523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity delays diagnosis and increases disability at diagnosis in MS.
    Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Neurology; 2009 Jan; 72(2):117-24. PubMed ID: 18971448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.